Join to View Full Profile
1500 Duarte RdDuarte, CA 91010
Phone+1 626-256-4673
Fax+1 626-301-8256
Dr. Rosenzweig is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Blood & Bone Marrow Transplant, 2009 - 2011
Boston University Medical CenterFellowship, Hematology and Medical Oncology, 2006 - 2009- Boston University Medical CenterResidency, Internal Medicine, 2001 - 2004
University of Arizona College of MedicineClass of 2001
Certifications & Licensure
CA State Medical License 2011 - 2027
NC State Medical License 2021 - 2022
NY State Medical License 2009 - 2013
MA State Medical License 2004 - 2011
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Safety Study of Carfilzomib in Patients With Previously-Treated Systemic Light Chain Amyloidosis Start of enrollment: 2013 Feb 01
- The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis Start of enrollment: 2016 Mar 01
- Leflunomide in Treating Patients With High-Risk Smoldering Multiple Myeloma Start of enrollment: 2019 Dec 11
- Join now to see all
Publications & Presentations
PubMed
- 10 citationsClonal Hematopoiesis and Cardiovascular Disease in Patients With Multiple Myeloma Undergoing Hematopoietic Cell Transplant.June-Wha Rhee, Raju Pillai, Tianhui He, Alysia Bosworth, Sitong Chen
JAMA Cardiology. 2024-01-01 - Policy and perspective on outpatient programs for autologous hematopoietic cell transplantation and immune-effector cell therapy administration.Scott R Goldsmith, May San-Rozano, Justine Katindoy, Janet Rattanapichetkul, Michael Rosenzweig
Frontiers in Immunology. 2024-01-01 - Case report: Treatment of parkinsonism secondary to ciltacabtagene autoleucel using a combination dopaminergic regimen.Raya Aliakbar, Olga Manouvakhova, Cindy Wong, Myo Htut, Johannes Pulst-Korenberg
Frontiers in Immunology. 2024-01-01
Press Mentions
Recommendations from FDA-AACR Workshop to Increase African American Representation in Multiple Myeloma Clinical TrialsApril 9th, 2021
Novel Approaches Emerge in AL AmyloidosisApril 27th, 2018
Working TogetherOctober 10th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
